Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RMTI is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
5 top institutions tracked
Sentiment: neutral
Last trade: sell 9 days ago
Red flags: 6
34 filers reported a long position in RMTI for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $677.7K | 1.2M | +4% |
| GEODE CAPITAL MANAGEMENT, LLC | $213.9K | 364.1K | -15.2% |
| RENAISSANCE TECHNOLOGIES LLC | $198K | 359.7K | -43.7% |
| JANE STREET GROUP, LLC | $135K | 245.2K | +210.6% |
| VANGUARD FIDUCIARY TRUST CO | $128.2K | 232.7K | +0.6% |
| Wealthspire Advisors, LLC | $83.6K | 151.8K | Unchanged |
| BlackRock, Inc. | $79.7K | 144.8K | -38.8% |
| STATE STREET CORP | $55.5K | 100.9K | Unchanged |
| NORTHERN TRUST CORP | $50.6K | 91.9K | -12.1% |
| UBS Group AG | $38.5K | 70K | -60.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.